Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 511)
Posted On: 01/15/2021 1:42:50 PM
Post# of 154130
Avatar
Posted By: ClosetInvestor
Re: CDiddy #72877
Primary Endpoint of the M2M trial: change in total symptom score. Simple math as the scores are already provided by the trial site. Example: PX1 day 0 score of 8 minus day 14 score of 3, equals a 5 point reduction. A simple excel document could complete the equations..

Primary Endpoint if the S/C trial: All cause mortality at day 28. Simple math again.

There’s not much more time needed to calculate a reduction in change in symptom score then there is to calculate all cause mortality. Amarex is not hand jamming these calculations, there are programs to assist in compiling the data and making the calculations.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site